| 1 | basic amino acid transport (GO:0015802) | 7.54344515 |
| 2 | sulfation (GO:0051923) | 7.05684845 |
| 3 | chemosensory behavior (GO:0007635) | 7.01533868 |
| 4 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 6.80988461 |
| 5 | inner cell mass cell proliferation (GO:0001833) | 6.62683710 |
| 6 | G-protein coupled receptor internalization (GO:0002031) | 6.46159663 |
| 7 | heart valve formation (GO:0003188) | 6.43491557 |
| 8 | mRNA polyadenylation (GO:0006378) | 6.24709407 |
| 9 | Notch signaling involved in heart development (GO:0061314) | 5.99506059 |
| 10 | cellular response to ATP (GO:0071318) | 5.89860515 |
| 11 | negative regulation of axon guidance (GO:1902668) | 5.74916527 |
| 12 | response to pheromone (GO:0019236) | 5.73732514 |
| 13 | RNA polyadenylation (GO:0043631) | 5.66466045 |
| 14 | negative regulation of platelet activation (GO:0010544) | 5.46294409 |
| 15 | post-anal tail morphogenesis (GO:0036342) | 5.41142918 |
| 16 | primitive streak formation (GO:0090009) | 5.23694793 |
| 17 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.20338598 |
| 18 | cardiac right ventricle morphogenesis (GO:0003215) | 5.06393443 |
| 19 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 5.04895752 |
| 20 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.98735573 |
| 21 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.98735573 |
| 22 | cardiac epithelial to mesenchymal transition (GO:0060317) | 4.93329279 |
| 23 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 4.78843859 |
| 24 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 4.77297403 |
| 25 | histone mRNA metabolic process (GO:0008334) | 4.77209714 |
| 26 | heart trabecula morphogenesis (GO:0061384) | 4.21286768 |
| 27 | coronary vasculature morphogenesis (GO:0060977) | 3.99070137 |
| 28 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.94283546 |
| 29 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.88028571 |
| 30 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.81850252 |
| 31 | negative regulation of digestive system process (GO:0060457) | 3.80816455 |
| 32 | dopamine transport (GO:0015872) | 3.78196542 |
| 33 | regulation of vasculogenesis (GO:2001212) | 3.72109678 |
| 34 | retinal cone cell development (GO:0046549) | 3.67183287 |
| 35 | forebrain neuron development (GO:0021884) | 3.64721995 |
| 36 | regulation of metalloenzyme activity (GO:0048552) | 3.62362956 |
| 37 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 3.61005942 |
| 38 | cardiac left ventricle morphogenesis (GO:0003214) | 3.60031679 |
| 39 | amyloid precursor protein catabolic process (GO:0042987) | 3.58800851 |
| 40 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.58173439 |
| 41 | estrogen biosynthetic process (GO:0006703) | 3.57604943 |
| 42 | nonmotile primary cilium assembly (GO:0035058) | 3.53755416 |
| 43 | vagina development (GO:0060068) | 3.41460822 |
| 44 | negative regulation by host of viral transcription (GO:0043922) | 3.40485578 |
| 45 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.32757260 |
| 46 | ATP synthesis coupled proton transport (GO:0015986) | 3.32757260 |
| 47 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.31548531 |
| 48 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.30413111 |
| 49 | positive regulation of prostaglandin secretion (GO:0032308) | 3.28730854 |
| 50 | regulation of axon guidance (GO:1902667) | 3.27516896 |
| 51 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.25682317 |
| 52 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.25682317 |
| 53 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.24707868 |
| 54 | uterus development (GO:0060065) | 3.23128210 |
| 55 | transmission of nerve impulse (GO:0019226) | 3.22019790 |
| 56 | regulation of platelet aggregation (GO:0090330) | 3.20609417 |
| 57 | rRNA methylation (GO:0031167) | 3.20071826 |
| 58 | positive regulation of gastrulation (GO:2000543) | 3.20057230 |
| 59 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.19756516 |
| 60 | endocardial cushion morphogenesis (GO:0003203) | 3.19094388 |
| 61 | regulation of cGMP metabolic process (GO:0030823) | 3.18268920 |
| 62 | positive regulation of fatty acid transport (GO:2000193) | 3.17994913 |
| 63 | aorta morphogenesis (GO:0035909) | 3.16029933 |
| 64 | iron ion import (GO:0097286) | 3.15271678 |
| 65 | positive regulation of protein kinase C signaling (GO:0090037) | 3.14794562 |
| 66 | negative regulation of mast cell activation (GO:0033004) | 3.12648559 |
| 67 | response to gravity (GO:0009629) | 3.12382287 |
| 68 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.12050791 |
| 69 | negative regulation of axon extension (GO:0030517) | 3.06825384 |
| 70 | regulation of prostaglandin secretion (GO:0032306) | 3.01979429 |
| 71 | positive regulation of cGMP metabolic process (GO:0030825) | 3.01868409 |
| 72 | intracellular pH reduction (GO:0051452) | 2.99721291 |
| 73 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 2.99016876 |
| 74 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.98227655 |
| 75 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.98075280 |
| 76 | embryonic axis specification (GO:0000578) | 2.97898820 |
| 77 | cGMP biosynthetic process (GO:0006182) | 2.97478885 |
| 78 | trabecula morphogenesis (GO:0061383) | 2.97206845 |
| 79 | ventricular septum morphogenesis (GO:0060412) | 2.95901787 |
| 80 | regulation of cell maturation (GO:1903429) | 2.93255421 |
| 81 | establishment of tissue polarity (GO:0007164) | 2.93060402 |
| 82 | establishment of planar polarity (GO:0001736) | 2.93060402 |
| 83 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.87582921 |
| 84 | regulation of thymocyte apoptotic process (GO:0070243) | 2.86132443 |
| 85 | post-embryonic morphogenesis (GO:0009886) | 2.85861747 |
| 86 | type B pancreatic cell development (GO:0003323) | 2.83609959 |
| 87 | cardiac ventricle morphogenesis (GO:0003208) | 2.82047511 |
| 88 | heart trabecula formation (GO:0060347) | 2.81532529 |
| 89 | regulation of mitochondrial translation (GO:0070129) | 2.81380137 |
| 90 | somitogenesis (GO:0001756) | 2.79370070 |
| 91 | ventricular cardiac muscle cell development (GO:0055015) | 2.79300021 |
| 92 | positive regulation of macrophage cytokine production (GO:0060907) | 2.78084198 |
| 93 | heart valve morphogenesis (GO:0003179) | 2.77900624 |
| 94 | maternal behavior (GO:0042711) | 2.77789382 |
| 95 | ganglion development (GO:0061548) | 2.76713679 |
| 96 | rRNA modification (GO:0000154) | 2.76195191 |
| 97 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.75496379 |
| 98 | convergent extension (GO:0060026) | 2.73781993 |
| 99 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.72217790 |
| 100 | histone mRNA catabolic process (GO:0071044) | 10.0918872 |
ETF1P3 
